Tuberculosis (TB) still remains the leading cause of mortality due to bacterial pathogen. The only currently available vaccine against TB, Bacille Calmette-GuĂŠrin (BCG) is at best credited with a 50% overall protective efficacy. Skin testing with purified protein derivative (PPD) from Mycobacterium tuberculosis is the method of detecting BCG-induced cell mediated immunity, in vivo. In the previous study we found that approximately 60% young volunteers with no history of TB, who had been subjected to neonatal BCG vaccination and revaccination(s) at school age, developed delayed type hypersensitivity (DTH) to tuberculin. The remaining volunteers were persistently tuberculin negative. Moreover, we found a significant association between BCG d...
Background: The century-old Mycobacterium bovis Bacillus Calmette-Guerin (BCG) remains the only lice...
The formation of a scar after Mycobacterium bovis Bacillus Calmette-Guérin (BCG) vaccination influen...
The role of T-cells in immunity against Mycobacterium tuberculosis (M. tuberculosis) infection has b...
Tuberculosis (TB) still remains the leading cause of mortality due to bacterial pathogen. The only c...
Purified protein derivative (PPD) RT23-recalled T-cell receptor (TCR) Vß expression was studied in t...
The development of effective immunoprophylaxis against tuberculosis (TB) remains a global priority, ...
Mycobacterium tuberculosis (Mtb) is principally a pulmonary pathogen infecting one-third of the worl...
Tuberculosis (TB) is the leading cause of mortality from a single infectious agent, Mycobacterium tu...
Mycobacterium tuberculosis is the causative agent of human TB, which is responsible for 26% of all p...
The tuberculosis (TB) vaccine Bacillus Calmette-Guérin (BCG) was introduced 100 years ago, but as it...
Tuberculosis is a major cause of death due to an infection in mankind. BCG vaccine protects against ...
There is no effective vaccine against tuberculosis (TB). The only available TB-vaccine, M. bovis BCG...
The efficacy of Bacillus Calmette-Guerin (BCG) vaccination in protection against pulmonary tuberculo...
Tuberculosis (TB) remains one of the world’s most serious infectious diseases. It is estimated that ...
One possibility to improve the efficacy of BCG vaccine against TB is to create a recombinant BCG (r-...
Background: The century-old Mycobacterium bovis Bacillus Calmette-Guerin (BCG) remains the only lice...
The formation of a scar after Mycobacterium bovis Bacillus Calmette-Guérin (BCG) vaccination influen...
The role of T-cells in immunity against Mycobacterium tuberculosis (M. tuberculosis) infection has b...
Tuberculosis (TB) still remains the leading cause of mortality due to bacterial pathogen. The only c...
Purified protein derivative (PPD) RT23-recalled T-cell receptor (TCR) Vß expression was studied in t...
The development of effective immunoprophylaxis against tuberculosis (TB) remains a global priority, ...
Mycobacterium tuberculosis (Mtb) is principally a pulmonary pathogen infecting one-third of the worl...
Tuberculosis (TB) is the leading cause of mortality from a single infectious agent, Mycobacterium tu...
Mycobacterium tuberculosis is the causative agent of human TB, which is responsible for 26% of all p...
The tuberculosis (TB) vaccine Bacillus Calmette-Guérin (BCG) was introduced 100 years ago, but as it...
Tuberculosis is a major cause of death due to an infection in mankind. BCG vaccine protects against ...
There is no effective vaccine against tuberculosis (TB). The only available TB-vaccine, M. bovis BCG...
The efficacy of Bacillus Calmette-Guerin (BCG) vaccination in protection against pulmonary tuberculo...
Tuberculosis (TB) remains one of the world’s most serious infectious diseases. It is estimated that ...
One possibility to improve the efficacy of BCG vaccine against TB is to create a recombinant BCG (r-...
Background: The century-old Mycobacterium bovis Bacillus Calmette-Guerin (BCG) remains the only lice...
The formation of a scar after Mycobacterium bovis Bacillus Calmette-Guérin (BCG) vaccination influen...
The role of T-cells in immunity against Mycobacterium tuberculosis (M. tuberculosis) infection has b...